Endovia Health Sciences, Inc.
EDVA
22 hedge funds and large institutions have $2.83M invested in Endovia Health Sciences, Inc. in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
603% more call options, than puts
Call options by funds: $527K | Put options by funds: $75K
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more funds holding
Funds holding: 22 → 22 (0)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
58% less capital invested
Capital invested by funds: $6.81M → $2.83M (-$3.98M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$168K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$104K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$36.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$32.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$26.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$398K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$253K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$107K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$25.4K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$11.8K |
EDVA Hedge Fund Activity: Q3 2022 in Review
22 of the 5,827 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q3 2022, worth a combined $2.83M — down 58% from $6.81M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new EDVA positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $168K. The largest seller was Vanguard Group, cutting an estimated $398K.
- 22 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $2.83M of Endovia Health Sciences, Inc. stock for Q3 2022, down 58% quarter-over-quarter.
- 3 funds opened new Endovia Health Sciences, Inc. positions in Q3 2022 and 2 closed out, a net change of +1 holder.
- The largest Endovia Health Sciences, Inc. buyer in Q3 2022 was Virtu Financial, an estimated $168K added.
- The largest Endovia Health Sciences, Inc. seller in Q3 2022 was Vanguard Group, an estimated $398K sold.
Based on aggregated 13F filings for Q3 2022.